menu
  • For Information About Current Clinical Trials

  • 513-585-1777 513-585-1737 (Physician Referral Line) LindnerTrials@TheChristHospital.com
  • Home
  • About Us
    • History
    • Institutional Review Board
  • Contact Us
    • Maps and Directions

CyndRX Seal to Heal

Enroll Your Patient Now Accepting
  • Clinical Trials
    • Cell Therapy / Gene Therapy
    • Dementia
    • Diabetes / Hypertension / Lipids
    • Heart Attack / ACS
    • Heart Failure / CHF
    • Heart Rhythm Disorder / EP
    • Heart Surgery / CVS
    • Heart Valve Disease
    • Heart Vessel Blockage / CAD
    • Orthopaedics / Spine
    • Peripheral Vascular Blockage / PAD
    • Pulmonary Hypertension
    • Women's Health
    • Other
  • Research
  • Clinical Trials
  • Heart Vessel Blockage / CAD
  • CyndRX Seal to Heal

CyndRX Seal to Heal

The SEAL TO HEAL Study: Study to EvALuate Time TO HEmostasis of AbsourbaSeaL

To evaluate the safety and effectiveness of percutaneous common femoral artery puncture site closure with AbsorbaSeal 5.6.7F Vascular Closure Device (VCD) in adults following elective, non-emergent diagnostic or interventional vascular catheterization procedures

Please use this link for further information:
clinicaltrials.gov


Primary Investigator: Dean Kereiakes

Enrolling

The Carl and Edyth Lindner Research Center
at The Christ Hospital
2123 Auburn Avenue, Suite 424, Cincinnati, OH 45219

513-585-1777
513-585-1737 (Physician Referral Line)
513-585-4858 (Fax)
LindnerTrials@TheChristHospital.com

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2023 All rights reserved.

Web Design by TBH Creative